Company Overview

Strainsforpains, Inc. (OTC: EBYH) is a publicly traded company that has historically been associated with health, wellness, and cannabis-adjacent consumer products through operations tied to cannabidiol (CBD) and alternative wellness distribution. Public disclosures indicate that the company pursued business opportunities connected to online retailing, direct-to-consumer wellness products, and distribution platforms targeting pain management and lifestyle-oriented health markets. Available public records also show periods of corporate restructuring, changes in strategic direction, and limited operating activity.

The company’s historical positioning centered on leveraging digital commerce and consumer demand for hemp-derived and wellness-related products. However, publicly available disclosures regarding sustained revenue generation, active operating scale, and long-term commercial execution remain limited. Based on available OTC market disclosures and historical filings, the company appears to have undergone multiple operational transitions over time. Data regarding current large-scale commercial operations, market share, or sustained profitability is inconclusive based on available public sources.

Business Operations

Historically, the company’s operations were associated with online sales channels and wellness-oriented product distribution. Public disclosures and OTC market information suggest involvement in consumer products connected to CBD and related health categories, though the extent of active product commercialization has not been consistently documented in recent public filings. The company’s business model appeared to rely primarily on product sales, licensing opportunities, and strategic partnerships within emerging wellness and alternative health sectors.

Information regarding distinct operating segments, international business divisions, or material revenue concentration is limited in publicly available records. No consistently verified evidence was identified indicating large-scale manufacturing infrastructure, proprietary pharmaceutical technology platforms, or globally diversified operating assets. Publicly available disclosures also do not clearly confirm major active subsidiaries, joint ventures, or institutional partnerships at significant scale. Data regarding current operational scope remains inconclusive based on available public sources.

Strategic Position & Investments

Historically, the company’s strategic direction appeared focused on participating in emerging consumer wellness and cannabis-adjacent markets during periods of heightened investor interest in CBD and alternative health products. Available public information indicates that management explored branding opportunities, digital distribution initiatives, and potential acquisitions or partnerships tied to wellness-oriented businesses. However, independently verifiable evidence of transformative acquisitions or major capital investments remains limited.

The company operated in a sector characterized by evolving regulation, fragmented competition, and rapid shifts in consumer demand. Publicly accessible records do not provide substantial evidence of major institutional investments, significant portfolio companies, or proprietary emerging technologies comparable to larger participants in the cannabis, biotechnology, or pharmaceutical sectors. Any assessment of long-term strategic positioning should therefore be treated cautiously due to limited recent operational transparency and constrained public reporting.

Geographic Footprint

Publicly available information indicates that Strainsforpains, Inc. primarily focused on the United States market, particularly through online consumer distribution channels. No substantial evidence was identified confirming extensive physical international operations, multinational manufacturing assets, or broad overseas commercial infrastructure. The company’s public market presence has primarily been through the U.S. over-the-counter securities market.

Headquarters and operational locations referenced in historical records have varied over time due to corporate changes and restructuring activity. Available disclosures do not clearly establish a large international footprint across Europe, Asia-Pacific, Latin America, or the Middle East. Data regarding current international operations or foreign investment activity is inconclusive based on available public sources.

Leadership & Governance

Public information regarding current executive leadership and governance structure is limited and, in some cases, inconsistent across OTC disclosures and historical corporate records. The company has experienced periods of transition, and updated executive information has not been consistently maintained through widely accessible public filings. As a result, some leadership details cannot be independently verified through multiple current sources.

Known or historically referenced executives associated with the company include:

• Wayne Cockburn – Former executive leadership role associated with historical company operations
• James E. Thompson – Historical management association referenced in public market disclosures

Available public disclosures do not provide a clearly articulated long-term governance philosophy or detailed strategic management framework comparable to larger SEC-reporting issuers. Information regarding independent board composition, governance committees, or institutional oversight mechanisms is limited in current publicly accessible records.